Global® AP™ Total Shoulder Arthroplasty

Sponsor
DePuy Orthopaedics (Industry)
Overall Status
Completed
CT.gov ID
NCT00719771
Collaborator
(none)
64
4
1
69
16
0.2

Study Details

Study Description

Brief Summary

This study will evaluate the clinical performance of DePuy Global® AP™ Shoulder prosthesis using the anchor pegged glenoid component and clinical and radiographic evaluations.

Condition or Disease Intervention/Treatment Phase
  • Device: Global® AP™ Total shoulder arthroplasty
N/A

Detailed Description

The purpose of the study is to determine the difference between pre-operative and post-operative levels of patient satisfaction, shoulder function, radiographic alignment, shoulder pain and patient satisfaction in patients receiving a Global® AP™ shoulder prosthesis for glenohumeral arthritis.

Study Design

Study Type:
Interventional
Actual Enrollment :
64 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: Global® AP™ Shoulder

Global® AP™ Shoulder

Device: Global® AP™ Total shoulder arthroplasty
Total shoulder arthroplasty
Other Names:
  • Global® AP™ Shoulder
  • Outcome Measures

    Primary Outcome Measures

    1. Constant Shoulder Score [Pre-op, 6, 12, 24 months]

    Secondary Outcome Measures

    1. SF-12 [Pre-op, 6,12, 24 months]

    2. Penn/ASES [Pre-Op, 6, 12, and 24 months]

    3. Radiographic Data [Pre-Op, 6 weeks, 6, 12, and 24 months]

    4. Quality of Life Survey [6 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients selected for inclusion will present for primary shoulder arthroplasty with a diagnosis of osteoarthritis and will consent to participate.
    Exclusion Criteria:
    • Are under 18 years of age or over 70

    • Diagnosis of AVN, Inflammatory Arthritis, Fracture or Malunion.

    • Have a hemi-arthroplasty

    • Have destruction of the proximal humerus that precludes rigid fixation of the humeral component

    • Have arthritis with insufficient cuff tissue

    • Have had a failed rotator cuff surgery

    • Have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified

    • Have evidence of active infection

    • Present with a condition of neuromuscular compromise of the shoulder (e.g., neuropathic joints or brachial plexus injury with a flail shoulder joint) - Have a known active metastatic or neoplastic disease

    • Are unwilling or unable to comply with a rehabilitation program or would fail to return for the postoperative follow-up visits prescribed by the protocol

    • Are skeletally immature.

    • Have a known allergic reaction to implant metals, polyethylene or a tissue reaction to corrosion or wear products

    • Have other conditions such as central nervous system disturbances, alcohol or drug addiction, etc. that may make effective evaluation of the joint replacement difficult or impossible

    • Are currently participating in another clinical study

    • Are taking > 10mg/day corticosteroids (e.g. prednisone) excluding inhalers, within 3 months prior to surgery

    • Are currently involved in any personal injury litigation, medical legal or worker's compensation claims.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The CORE Institute Phoenix Arizona United States 85027
    2 Mission Hospitals Research Institute Asheville North Carolina United States 28801
    3 Wellington Orthopaedics and Sports Medicine Cincinnati Ohio United States 45230
    4 Rosenberg Cooley Metcalf Clinic Park City Utah United States 84060

    Sponsors and Collaborators

    • DePuy Orthopaedics

    Investigators

    • Study Director: Sam Himden, BA, DePuy Orthopaedics

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    DePuy Orthopaedics
    ClinicalTrials.gov Identifier:
    NCT00719771
    Other Study ID Numbers:
    • 05071
    First Posted:
    Jul 22, 2008
    Last Update Posted:
    May 22, 2014
    Last Verified:
    Dec 1, 2013
    Keywords provided by DePuy Orthopaedics
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 22, 2014